AXCYNSIS AXCYNSIS THERAPEUTICS Trademark
Trademark Overview
On Tuesday, July 23, 2024, a trademark application was filed for AXCYNSIS AXCYNSIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AXCYNSIS AXCYNSIS THERAPEUTICS trademark a serial number of 79407408. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, January 15, 2025. This trademark is owned by AXCYNSIS THERAPEUTICS PTE. LTD.. The AXCYNSIS AXCYNSIS THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals; pharmaceutical drugs; pharmaceutical products; biopharmaceuticals for the treatment of cancer; chemical preparations for pharmaceutical purposes.
In vitro testing for medical and pharmaceutical use; in vitro analysis for medical and pharmaceutical use.
Development of pharmaceuticals; pharmaceutical research and development; research and development for the pharmaceutical industry; biochemical research; biochemical research and analysis; biochemical research and development; biochemistry research services; bioinorganic chemistry research; biological research; biological research and analysis; biological research laboratory services; biological research services; biomedical research services; bioorganic chemistry research; biotechnological research; biotechnology research; chemical research; chemical research and analysis; chemical research and analysis services; chemical research laboratory services; chemical research services; chemical technological research; chemistry research; clinical research; consultancy in the field of pharmaceutical research; consultancy in the field of scientific research; consultancy in the field of technological research; consultancy relating to pharmaceutical research and development; consultancy relating ...
General Information
| Serial Number | 79407408 |
| Word Mark | AXCYNSIS AXCYNSIS THERAPEUTICS |
| Filing Date | Tuesday, July 23, 2024 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Wednesday, January 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceuticals; pharmaceutical drugs; pharmaceutical products; biopharmaceuticals for the treatment of cancer; chemical preparations for pharmaceutical purposes. |
| Goods and Services | In vitro testing for medical and pharmaceutical use; in vitro analysis for medical and pharmaceutical use. |
| Goods and Services | Development of pharmaceuticals; pharmaceutical research and development; research and development for the pharmaceutical industry; biochemical research; biochemical research and analysis; biochemical research and development; biochemistry research services; bioinorganic chemistry research; biological research; biological research and analysis; biological research laboratory services; biological research services; biomedical research services; bioorganic chemistry research; biotechnological research; biotechnology research; chemical research; chemical research and analysis; chemical research and analysis services; chemical research laboratory services; chemical research services; chemical technological research; chemistry research; clinical research; consultancy in the field of pharmaceutical research; consultancy in the field of scientific research; consultancy in the field of technological research; consultancy relating to pharmaceutical research and development; consultancy relating to research and development in the field of therapeutics; dna analysis services for scientific research purposes; dna screening for scientific research purposes; dna sequencing for medical research purposes; dna sequencing technology research; gene therapy research; genetic research; genetic testing for scientific research purposes; laboratory research; laboratory research in the field of chemistry; laboratory research in the field of gene expression; laboratory research in the field of pharmaceuticals; laboratory research services relating to pharmaceuticals; medical research; medical research in the field of oncology; medical research laboratory services; medical research services; pharmaceutical research and development services; pharmaceutical research consultancy; pharmaceutical research services; preparation of reports relating to chemical research; preparation of reports relating to scientific research; product research; product research and development; providing information about medical and scientific research in the field of pharmaceuticals; providing information relating to scientific research in the fields of biochemistry and biotechnology; providing information, including online, about scientific and technological services and research and design relating thereto; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of information relating to scientific research; provision of information relating to technological research; provision of research services; research and development in the field of biotechnology; research and development of new products; research and development of new products for others; research and development services for the pharmaceutical industry; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of biochemistry; research and development services in the field of biotechnology; research and development services in the field of chemistry; research and development services in the field of pharmaceutical preparations; research in the field of biology; research in the field of biomedicine; research in the field of biotechnology; research in the field of chemistry; research on the subject of pharmaceuticals; research relating to biotechnology; research relating to chemistry; research relating to chemicals; research relating to medicine; research relating to molecular sciences; research relating to pharmaceuticals; research relating to science; research services; research to develop new products; scientific and industrial research; scientific and technological services and research and design relating thereto; scientific and technological services and research and development relating thereto; scientific research; scientific research and analysis; scientific research and development; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of biotechnology; scientific research into the development of new products; scientific research relating to biology; scientific research relating to chemistry; scientific research relating to chemical products; scientific research relating to genetics; scientific research services; technical research in the field of pharmaceutical studies; technical research projects and studies. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AXCYNSIS THERAPEUTICS PTE. LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | SG |
Trademark Events
| Event Date | Event Description |
| Thursday, October 24, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 8, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 10, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, January 15, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, January 16, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
